Cyclolab is the first generic manufacturer of an excipient: Sulfobutyl-Betadex under the trade name Dexolve, a potent solubility and stability enhacer, increasing bioavailability, with the reduction of side effects, irritation, among further advantages of cyclodextrins in the pharmaceutical formulation.
